Version 1
: Received: 1 May 2024 / Approved: 2 May 2024 / Online: 2 May 2024 (10:03:55 CEST)
How to cite:
Pham, T.-P.-T.; Le, T.-T.-D.; Cao, P.-T.-N.; Ho, V.-T.-N.; Vu, T.-M.-H.; Le, T.-H.-T.; Pham, H.-T.-X.; Mafruhah, O. R.; Pham, T.-T.-L.; Hsieh, M.-T.; Ha, H.-A.; Hoang, T.-V. Comparing the Cardiovascular Risk-Reducing Effects of Polyunsaturated Fatty Acids in Fish Oil and Krill Oil: A Network Meta-Analysis. Preprints2024, 2024050128. https://doi.org/10.20944/preprints202405.0128.v1
Pham, T.-P.-T.; Le, T.-T.-D.; Cao, P.-T.-N.; Ho, V.-T.-N.; Vu, T.-M.-H.; Le, T.-H.-T.; Pham, H.-T.-X.; Mafruhah, O. R.; Pham, T.-T.-L.; Hsieh, M.-T.; Ha, H.-A.; Hoang, T.-V. Comparing the Cardiovascular Risk-Reducing Effects of Polyunsaturated Fatty Acids in Fish Oil and Krill Oil: A Network Meta-Analysis. Preprints 2024, 2024050128. https://doi.org/10.20944/preprints202405.0128.v1
Pham, T.-P.-T.; Le, T.-T.-D.; Cao, P.-T.-N.; Ho, V.-T.-N.; Vu, T.-M.-H.; Le, T.-H.-T.; Pham, H.-T.-X.; Mafruhah, O. R.; Pham, T.-T.-L.; Hsieh, M.-T.; Ha, H.-A.; Hoang, T.-V. Comparing the Cardiovascular Risk-Reducing Effects of Polyunsaturated Fatty Acids in Fish Oil and Krill Oil: A Network Meta-Analysis. Preprints2024, 2024050128. https://doi.org/10.20944/preprints202405.0128.v1
APA Style
Pham, T. P. T., Le, T. T. D., Cao, P. T. N., Ho, V. T. N., Vu, T. M. H., Le, T. H. T., Pham, H. T. X., Mafruhah, O. R., Pham, T. T. L., Hsieh, M. T., Ha, H. A., & Hoang, T. V. (2024). Comparing the Cardiovascular Risk-Reducing Effects of Polyunsaturated Fatty Acids in Fish Oil and Krill Oil: A Network Meta-Analysis. Preprints. https://doi.org/10.20944/preprints202405.0128.v1
Chicago/Turabian Style
Pham, T., Hai-Anh Ha and Thi-Van Hoang. 2024 "Comparing the Cardiovascular Risk-Reducing Effects of Polyunsaturated Fatty Acids in Fish Oil and Krill Oil: A Network Meta-Analysis" Preprints. https://doi.org/10.20944/preprints202405.0128.v1
Abstract
The study aimed to compare the cardiovascular benefits of Omega-3 Polyunsaturated Fatty Acids from fish oil versus krill oil in different forms and dosages. Following PRISMA 2015, data analysis with R software, and databases were searched from 1993 to 2023, (ID PROSPERO: CRD42024502338). Sixty high-quality studies were analyzed, covering various forms of fish oil and krill oil at different dosages (fish oil (ethyl ester-EE, triglyceride-TG, re-esterified triglycerides-rTG, capsules, emulsion-EM); krill oil (phospholipid/free fatty acid-PL/FFA, high concentration phospholipid-HPL, low concentration phospholipid-LPL)). Meta-analysis revealed that krill oil with phospholipid/free fatty acid at doses 2000-2900 mg effectively lowered triglycerides, while fish oil in ethyl ester form at doses above 3000 mg significantly reduced total cholesterol. Fish oil in triglyceride form at doses 2000-2900 mg and other variations positively impacted HDL-C levels. Fish oil in EE form above 3000 mg and triglyceride form below 2000 mg notably reduced LDL-C. However, there was limited effectiveness observed for other interventions. Analysis for LDL-C exhibited publication bias, while other parameters demonstrated reliability (Egger's test). In conclusion, krill oil - PL/FFA, Fish oil - EE above 3000 mg, Fish oil - TG 2000-3000 mg, and fish oil - rTAG 300-1900 mg effectively in reducing heart risk patients.
Medicine and Pharmacology, Dietetics and Nutrition
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.